Under the 2021 WHO classification, IDH-mutant tumors are now classified as ‘astrocytoma, IDH-mutant, WHO grade 4’ rather than ‘glioblastoma’, although prior studies frequently group them under the broader term glioblastoma. This evidence concerns the gene IDH1 and glioblastoma.